You’re reading the web edition of STAT Health Tech, our guide to how tech is transforming the life sciences. Sign up to get this newsletter delivered in your inbox every Tuesday and Thursday.
The gray area of telehealth’s weight loss ads
Companies including Ro and Calibrate have capitalized on new weight loss drugs by launching telehealth services dedicated to prescribing Wegovy and Ozempic. In Ro’s case, the company has launched with prominent subway ads that feature close-up pictures of people injecting themselves and simple pitches like “Wegovy to lose weight.”
This article is exclusive to STAT+ subscribers
Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.
Already have an account? Log in
Already have an account? Log in
To submit a correction request, please visit our Contact Us page.
STAT encourages you to share your voice. We welcome your commentary, criticism, and expertise on our subscriber-only platform, STAT+ Connect